Subscribe To
STTK / Shattuck Labs, Inc. (STTK) Q4 2022 Earnings Call Transcript
STTK News
By Zacks Investment Research
August 10, 2023
Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Lags Revenue Estimates
Shattuck Labs, Inc. (STTK) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to more_horizontal
By GlobeNewsWire
May 25, 2023
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (A
- SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pharm more_horizontal
By GlobeNewsWire
May 25, 2023
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (A
- SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pharm more_horizontal
By Zacks Investment Research
May 9, 2023
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue Estimates
Shattuck Labs, Inc. (STTK) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to more_horizontal
By Seeking Alpha
February 26, 2023
Shattuck Labs, Inc. (STTK) Q4 2022 Earnings Call Transcript
Shattuck Labs, Inc. (NASDAQ:STTK ) Q4 2022 Earnings Conference Call February 23, 2023 4:45 PM ET Company Participants Conor Richardson - Vice Presiden more_horizontal
By Seeking Alpha
November 12, 2022
Shattuck Labs, Inc. (STTK) Q3 2022 Earnings Call Transcript
Shattuck Labs, Inc. (NASDAQ:STTK ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Conor Richardson - Senior Directo more_horizontal
By Zacks Investment Research
May 13, 2022
Should You Buy Shattuck Labs (STTK) Ahead of Earnings?
Shattuck Labs (STTK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal
By GlobeNewsWire
March 9, 2022
Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa more_horizontal